[1] Wolny-Koladka K.Valuationof ITS-PCR and PCR MP techniques for Streptococcus agalactiae genetic differentiation[J].Med Dosw Mikrobiol,2014,66(3-4):149-160. [2] Crespo-Ortiz Mdel P,Castaeda-Ramirez CR,Recalde-Bolaos M,et al.Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital:a 17-year study[J].BMC Infect Dis,2014,3(8):1471-2334. [3] Chang B,Wada A,Hosoya M,et al.Characteristics of group B streptococcus isolated from infants with invasive infections:A population-based study in Japan[J].Jpn J Infect Dis,2014,67(5):356-360. [4] Florindo,Damiao V,Silvestre I,et al.Epidemiological surveillance of colonising goup B Steptococcus epidemiology in the Lisbon and Tagus Valley regions,Portugal(2015-2012):emergence of a new epidemic type IV/clonal complex 17 clone[J].Euro Surveill,2014,19(23):20825. [5] Goudarzi G,Ghafarzadeh M,Shakib P,et al.Culture and real-time PCR based maternal screening and antibiotic susceptibility for group B Streptococcus:An Iranian experience[J].Glob J Health Sci,2015,7(6):45075. [6] Soares GC,Alviano DS,da Silva Santos G,et al.Prevalence of group B streptococcus serotypes Ⅲ and Ⅴ in pregnant women of Rio de Janeiro,Brazil[J].Braz J Microbiol,2014,44(3):869-872. [7] Stafford IA,Stewart RD,Sheffield JS,et al.Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease[J].Obstet Gynecol,2012,120(1):123-129. [8] Clifford V,Heffernan HM,Grimwood K,et al.Variation in erythromycin and clindamycin resistance patterns between New Zealand and Australian B streptococcus isolates[J].Aust N Z J Obstet Gynaecol,2011,51(4):328-332. [9] Garland SM,Cottrill E,Markowski L,et al.Antimicrobial resistance in group B streptococcus:the Australian experience[J].J Med Microbiol,2011,60(2):230-235. [10] Ferrieri P,Lynfield R,Creti R,et al.Serotype IV and invasive group B streptococcus disease in neonates,Minnesota,USA,2000-2010[J].Emerg Infect Dis,2013,19(4):551-558. [11] Bergseng H,Afset JE,Radtke A,et al.Molecular and phenotypic characterization of invasive group B streptococcus strains from infants in Norway 2006-2007[J].Clin Microbiol Infect,2009,15(12):1182-1185. [12] Martins ER,Andreu A,Correia P,et al.Group B streptococci causing neonatal infections in Barcelona are a stable clonal population:18-year surveillance[J].J Clin Microbiol,2011,49(8):2911-2918. [13] Wang P,Ma Z,Tong J,et al.Serotype distribution,antimicrobial resistance,and molecular characterization of invasive group B Streptococcus isolates recovered from Chinese neonates[J].Int J Infect Dis,2015,37(8):115-118. [14] Verani JR,McGee L,Schrag SJ,et al.Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC,2010[J].MMWR Recomm Rep,2010,59(RR-10):1-36. [15] Paoletti LC,Guttormsen HK,Christian MS,et al.Neither antibody to a group B streptococcal conjugate vaccine nor the vaccine itself is teratogenic in rabbits[J].Human Vaccines,2008,4(6):435-443. [16] Nuccitelli A,Rinaudo CD,Maione D,Group B Streptococcus vaccine:state of the art[J].Ther Adv Vaccines,2015,3(3):76-90. [17] Yang HH,Mascuch SJ,Madoff LC,et al.Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein[J].Clin Vaccine Immunol,2008,15(7):1035-1041. [18] Maeland JA,Afset JE,Lyng RV,et al.Survey of immunological features of the Alpha-like proteins of streptococcus agalactiae[J].Clin Vaccine Immunol,2015,22(2):153-159. [19] Santi I,Grifantini R,Jiang SM,et al.CsrRS regulates group B streptococcus virulence gene expression in response to environmental pH:a new perspective on vaccine development[J].J Bacteriol,2009,191(17):5387-5397. [20] Jiang S,Park SE,Yadav P,et al.Regulation and function of Pilus island 1 in group B Streptococcus[J].J Bacteriol,2012,194(10):2479-2490. [21] Pannaraj PS,Edwards MS,Ewing KT,et al.Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation[J].Vaccine,2009,27(33):4452-4456. [22] Morozumi M,Wajima T,Kuwata Y,et al.Associations between capsular serotype,multilocus sequence type,and macrolide resistance in Streptococcus agalactiae isolates from Japanese infants with invasive infections[J].Epidemiol Infect,2014,142(4):812-819.
PDF(508 KB)
